15 minutes delayed
Comments
Loading...
Baudax Bio Inc Ordinary Shares
BXRXOTC
Baudax Bio Inc Ordinary Shares (OTC:BXRX) Stock, Earnings Estimates, EPS, And Revenue
Baudax Bio Inc Ordinary Shares reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 20
EPS
$-0.290
Quarterly Revenue
$0K
Annual Revenue
–
Analyze the earnings history of Baudax Bio Inc Ordinary Shares using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BXRX | Baudax Bio | -$1.49 | — | — | — | $0.00 | — | — | — | 08/14/2024 | Get Alert |
| BXRX | Baudax Bio | -$3.19 | — | — | — | $0.00 | — | — | — | 08/06/2024 | Get Alert |
| BXRX | Baudax Bio | -$15.60 | -$0.53 | -$0.29 | 45.28% | $238.00K | — | $0.00 | — | 11/20/2023 | Get Alert |
| BXRX | Baudax Bio | -$24.20 | -$2.04 | -$1.49 | 26.96% | $300.00K | — | $0.00 | — | 08/16/2023 | Get Alert |
| BXRX | Baudax Bio | -$150.00 | $5.75 | -$3.19 | -155.48% | $422.00K | — | $0.00 | — | 05/12/2023 | Get Alert |
| BXRX | Baudax Bio | -$176.40 | -$9.76 | -$4.25 | 56.45% | $400.00K | — | $310.00K | — | 02/23/2023 | Get Alert |
| BXRX | Baudax Bio | -$280.00 | -$21.20 | -$15.60 | 26.42% | $281.00K | $960.00M | $238.00K | -99.98% | 11/08/2022 | Get Alert |
| BXRX | Baudax Bio | -$287.20 | -$50.80 | -$27.60 | 45.67% | $201.00K | $770.00K | $300.00K | -61.04% | 08/11/2022 | Get Alert |
| BXRX | Baudax Bio | -$378.00 | -$94.00 | -$150.00 | -59.57% | $198.00K | $880.00K | $422.00K | -52.05% | 05/04/2022 | Get Alert |
| BXRX | Baudax Bio | -$126.00 | $58.80 | -$176.40 | -400.00% | $76.00K | $620.00K | $400.00K | -35.48% | 03/16/2022 | Get Alert |
| BXRX | Baudax Bio | $868.00 | -$210.00 | -$280.00 | -33.33% | $68.00K | $600.00K | $281.00K | -53.17% | 11/04/2021 | Get Alert |
| BXRX | Baudax Bio | -$2.41K | -$280.00 | -$294.00 | -5.00% | $349.00K | $470.00K | $201.00K | -57.23% | 08/05/2021 | Get Alert |
| BXRX | Baudax Bio | -$5.64K | -$266.00 | -$378.00 | -42.11% | $0.00 | $630.00K | $198.00K | -68.57% | 05/05/2021 | Get Alert |
| BXRX | Baudax Bio | -$1.09K | -$854.00 | -$126.00 | 85.25% | $0.00 | $1.63M | $76.00K | -95.34% | 02/16/2021 | Get Alert |
| BXRX | Baudax Bio | — | -$1.04K | $868.00 | 183.78% | — | $1.00M | $68.00K | -93.20% | 11/09/2020 | Get Alert |
| BXRX | Baudax Bio | -$1.58K | -$910.00 | -$2.41K | -164.62% | — | — | $349.00K | — | 08/10/2020 | Get Alert |
| BXRX | Baudax Bio | -$644.00 | — | -$5.64K | — | — | — | $0.00 | — | 05/08/2020 | Get Alert |
| BXRX | Baudax Bio | — | — | -$1.09K | — | — | — | $0.00 | — | 02/13/2020 | Get Alert |
Baudax Bio Inc Ordinary Shares (BXRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-20 | $-0.29 | $-0.53 | 45.3 % |
| Jun 2023 | 2023-08-16 | $-1.49 | $-2.04 | 27.0 % |
| Mar 2023 | 2023-05-12 | $-3.19 | $5.75 | -155.5 % |
| Dec 2022 | 2023-02-23 | $-4.25 | $-9.76 | 56.5 % |
Baudax Bio Inc Ordinary Shares (BXRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2022 | 2022-11-08 | $238.00K | $960.00M | -100.0 % |
| Jun 2022 | 2022-08-11 | $300.00K | $770.00K | -61.0 % |
| Mar 2022 | 2022-05-04 | $422.00K | $880.00K | -52.0 % |
| Dec 2021 | 2022-03-16 | $400.00K | $620.00K | -35.5 % |
FAQ
When is Baudax Bio Inc Ordinary Shares (OTC:BXRX) reporting earnings?
Baudax Bio Inc Ordinary Shares (BXRX) is scheduled to report earnings on August 14, 2024. The last reported earnings were for reported on November 20, 2023 for Q3.
What were the latest earnings per share (EPS) for Baudax Bio Inc Ordinary Shares (OTC:BXRX)?
The Actual EPS was $-0.29, which beat the estimate of $-0.53.
What were Baudax Bio Inc Ordinary Shares’s (OTC:BXRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.